Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Dr. Shahar Lev-Ari | Medicine and Health Sciences | Best Researcher Award

Visiting Faculty | Stanford University | United States

Dr. Shahar Lev-Ari is an accomplished academic with a strong educational foundation in cellular biology and medicine who has over many years built a distinguished career in health promotion, public health research, integrative medicine, and well-being interventions; Dr. Shahar Lev-Ari was trained in cellular biology and obtained his PhD after rigorous work in integrative medicine and intervention science, and his education included advanced training in health promotion science and mindfulness-based behavior change. In his professional experience, Dr. Shahar Lev-Ari has served as founding director of the Integrative Medicine Center & Laboratory of Medicinal Herbs and Cancer Research at the Institute of Oncology, led the Health Promotion Unit within the Integrated Cancer Prevention Center at Tel Aviv Medical Center, and formerly chaired the Department of Health Promotion, School of Public Health at Tel Aviv University; he is also a visiting scholar in Stanford University’s Department of Genetics and collaborates internationally in precision health and psychosocial interventions. Research interests of Dr. Shahar Lev-Ari focus on mindfulness and stress-reduction techniques, inquiry-based stress reduction (IBSR), salutogenesis, resilience, psychosocial health, mental well-being, interventions in at-risk populations (e.g. women with BRCA variants), longevity and protective behavioral and psychosocial factors, mind-body medicine, and digital health tools for well-being. He has developed skills in both quantitative and intervention research; expertise in randomized clinical trials, longitudinal cohort studies, psychosocial measurement, sleep assessments, behavior change, developing and evaluating interventions, public health promotion, multi-disciplinary collaborators, mixed-methods, psychosocial biometrics, and implementing rigorous designs. Dr. Shahar Lev-Ari has been recognized with awards and honours such as the Outstanding Scientist Award from the Israel Society for Complementary Medicine under the auspices of the Israeli Medical Association, and has received support from organizations such as the Rothschild Foundation, the Israeli Cancer Association, and chief scientists in education and medicine; he has also been invited to serve on editorial boards (e.g., Section Editor for Public Health in Journal of Clinical Medicine), and in national and global working groups on mental health promotion. In his published record, Dr. Shahar Lev-Ari has authored 81 documents, has accumulated 2,106 citations, and has h-index 22, demonstrating both breadth and impact. Overall, Dr. Shahar Lev-Ari embodies a scholar-practitioner who bridges fundamental biology, public health, psychosocial interventions and community health implementation, with leadership roles in research, mentorship, and translation of findings into interventions that improve psychological well-being and health outcomes in both general and vulnerable populations.

Profile:  Scopus | ORCID

Featured Publications

  1. Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel: A Randomized Clinical Trial — 2021; ~3 citations

  2. The Association Between the Sense of Coherence and the Self-Reported Adherence to Guidelines During the First Months of the COVID-19 Pandemic in Israel — 2022; number of citations

  3. The Use of Smart Devices for Mental Health Diagnosis and Care — 2022; number of citations

  4. A Novel Platform for Attenuating Immune Hyperactivity Using EXO-CD24 in COVID-19 and Beyond — 2022; number of citations

  5. Data From a One-Stop-Shop Comprehensive Cancer Screening Center — 2023; number of citations

  6. Mental Health for All: The Case for Investing in Digital Mental Health to Improve Global Outcomes, Access, and Innovation in Low-Resource Settings — 2023; number of citations

 

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Published on by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

 

Lei Tong | Medicine and Health Sciences | Best Researcher Award

Published on by Research Hypothesis

Lei Tong | Medicine and Health Sciences | Best Researcher Award

Dr Lei Tong, China Academy of Chinese Medical Sciences, China

Dr. Aayushi 🧪🎓 is a highly accomplished researcher in Chemical Sciences, securing an All India Rank of 02 in CSIR NET (Dec 2023) 🏆. She qualified IIT JAM (2017) and received prestigious scholarships, including the CBSE CSSS (2014-2019) and Thapar Institute Merit Scholarship (2018) 🎖️. Honored with the Young Achiever Award (2021) 🌟, she excelled in research, winning Best Oral Presentation at EMSD-2022 🗣️ and Best Poster Award at CEEMS Doctorate Scholar’s Day-2024 🖼️. Her work on carbon quantum dots for metal ion detection highlights her expertise in materials science and sensors 🔬⚛️.

Publication Profile

Orcid

Education

Dr. Lei Tong 🏮🔬 is a dedicated research assistant at the Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences (since August 2023). With a strong academic foundation, Dr. Tong earned a Ph.D. (2018-2023) and a Bachelor’s degree (2014-2018) from the University of Science and Technology Beijing 🎓. His research integrates traditional Chinese medicine with modern scientific methodologies, contributing to innovative medical advancements. Passionate about bridging ancient wisdom with contemporary research, Dr. Tong continues to explore fundamental theories in Chinese medicine to enhance healthcare solutions. 🌿📚🔎

Research

Dr. Lei Tong focuses on integrating stem cells, organoids, microfluidic chips, and single-cell omics 🧬🔬 to develop a multi-organoid chip model for understanding disease and syndrome interactions in Traditional Chinese Medicine (TCM) 🌿. This innovative approach deciphers the spatio-temporal evolution of TCM syndromes and their biological basis. Additionally, Dr. Tong utilizes chromatogram-mass spectrometry, bioinformatics, and metabolomics 🧪📊 to identify active components in classic prescriptions, tracing their path to the brain 🧠. His research unveils the multi-component, multi-cell, multi-target neuroprotective mechanisms of TCM, offering new insights into holistic healing and modern medical applications. 🌍💊

Project

Dr. Lei Tong is actively engaged in pioneering research in Traditional Chinese Medicine (TCM) 🌿🔬. He leads multiple prestigious projects, including the Youth Project of Beijing Natural Science Foundation (2024-2026) 🏅, and the Science and Technology Innovation Project of the China Academy of Chinese Medical Sciences (2023-2025) 💡. Additionally, he is part of the Special Project for Training Outstanding Young Scientific and Technological Talents (2023-2026) 🎓 and a key researcher at the Research Institute of Basic Theories of TCM (2024-2027) 📚. His work contributes to advancing innovative technologies and methodologies in TCM for future medical breakthroughs 🌏✨.

Research Focus

Dr. Lei Tong’s research primarily focuses on neurodegenerative diseases 🧠🦠, particularly Parkinson’s disease (PD) 🏥🧬. His work explores novel therapeutic strategies, including herbal medicine 🌿, stem cell therapy 🧑‍🔬🧫, and nanotechnology-based drug delivery 💊🔬. He investigates neuronal synaptic plasticity 🔗, oligodendrocyte apoptosis ⚡, and inflammation control 🔥 to mitigate PD progression. Additionally, his studies extend to brain organoids 🏗️🧠 for drug discovery and protein aggregation targeting 🏹 in neurodegeneration. His interdisciplinary approach also includes fluorescent sensing 🟣🔍 for cellular applications. Dr. Tong’s research bridges neuroscience, regenerative medicine, and nanotechnology for innovative neuroprotection strategies. 🚀

Publication Top Notes

Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases.

Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson’s Disease.

Targeting small heat shock proteins to degrade aggregates as a potential strategy in neurodegenerative diseases.

Human gingival mesenchymal stem cells improve movement disorders and tyrosine hydroxylase neuronal damage in Parkinson disease rats.

A porphyrin-triazatruxene dyad for ratiometric two-photon fluorescent sensing of intracellular viscosity.

Hydrogel supplemented with human platelet lysate enhances multi-lineage differentiation of mesenchymal stem cells.

Chitosan Hydrogel Supplemented with Metformin Promotes Neuron-like Cell Differentiation of Gingival Mesenchymal Stem Cells.

Comparative proteomics analysis of human stem cells from dental gingival and periodontal ligament.